DE
About us
Company
Strategy & Mission
Management
Career
Portfolio
Marketed products
Pipeline
Immunology
Virology
Scientific Publications
Partnering
Business Development
Solv4U
Investors & ESG
Investment Highlights
Share information
Ad-hoc News
Financial publications
Facts & Figures
Financial Calendar
Responsibility & ESG
Annual General Meeting
Capital Transactions
IR contact
News & Publications
Corporate News
Scientific Publications
Events & Press
Downloads
DE
23. April 2019 | Adhoc News
Marinomed Biotech AG announces top line results of the Phase III study for Budesolv
Marinomed Biotech AG
News & Publications
Adhoc-Announcement
The full Adhoc announcement is available as download here:
Marinomed Biotech AG announces top line results of the Phase III study for Budesolv
(116 KB)
